Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ONWARD MEDICAL BV EO -12

63E
Current price
4.66 EUR 0 EUR (0.00%)
Last closed 5.2 EUR
Company
ISIN NL0015000HT4
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 230 720 272 EUR
Yield for 12 month +32.39 %
1Y
3Y
5Y
10Y
15Y
63E
21.11.2021 - 28.11.2021

Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands. Address: Schimmelt 2, Eindhoven, Netherlands, NL-5656

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures 63E

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -35 439 110 EUR
Operating Margin TTM -9013.94 %
PE Ratio
Return On Assets TTM -41.83 %
PEG Ratio
Return On Equity TTM -133.61 %
Wall Street Target Price
Revenue TTM -189 827 EUR
Book Value 0.54 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -77.6 %
Dividend Yield
Gross Profit TTM -32 411 973 EUR
Earnings per share -1.1 EUR
Diluted Eps TTM -1.1 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 63E

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 63E

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 63E

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 290.96
Enterprise Value EBITDA -2.3804
Price Book MRQ 11.6996

Financials 63E

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 63E

For 52 weeks

2.01 EUR 6.6 EUR
50 Day MA 4.89 EUR
Shares Short Prior Month
200 Day MA 4.84 EUR
Short Ratio
Shares Short
Short Percent